From the unique lung cancer vascular environment with associated hypoxia and metabolic stress to a unique tolerance-inducing immunophenotype with glycocalyx shielding and CD8+ and NK cell repression by the lung cancer-cell glycocalyx, the various drivers of suppression promote tumor progression and invasion and metastasis. The gene discussed is CD8A; the disease is lung cancer.